|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Market and Health Care Reform in China 2008
Seed Planning, Oct 2008, Pages: 145
With total pharmaceutical production reaching RMB 648.9bn. in 2007, the Chinese pharmaceutical market has continued to maintain a two-digit growth dynamics. On the other hand, there remain a number of issues to be addressed before meeting the world standards. Over the past several years, the Chinese government has intensified its efforts to resolve the issues associated with intellectual property, drug quality, and briberies. One of the biggest ongoing issues is the national healthcare reform intended for universal health insurance coverage. The Chinese government initiated a preliminary implementation of basic health insurance for urban residents in July 2007, adopting a wide range of new policies including 'Separation of dispensing and prescribing functions', 'Implementation of Government-defined unified prices of essential drugs', 'Improvement of drug approval process as well as drug distribution system', and 'Intensification of environmental protection measures', etc.
Customers who bought this item also bought
China Chemical Pharmaceutical Industry Report, 2007
China Chemical Pharmaceutical Industry Report, 2007
China Pharmaceutical Chain Industry Report, 2007-2008
China Pharmaceutical Chain Industry Report, 2007-2008
China Pharmaceutical Logistics Industry Report, 2008
China Pharmaceutical Logistics Industry Report, 2008
The Pharmaceutical Market: New Zealand
China Pharmaceutical Market Report 2008
The Pharmaceutical Market: South Africa
The Pharmaceutical Market: Greece
Pharmaceutical Pricing and Reimbursement in China
State of the Pharmaceutical Industry, 2007
|
|
|
|
